Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Dell Technologies C | DELL | Nov 22, 2024 | 144.21 | +3.81 |
Delta Air Lines | DAL | Nov 22, 2024 | 63.34 | 0.00 |
Deluxe | DLX | Nov 22, 2024 | 23.25 | +1.31 |
Denali Capital Acquisition A | DECA | Nov 22, 2024 | 11.69 | 0.00 |
Denali Capital Acquisition Unit | DECAU | Nov 22, 2024 | 11.60 | 0.00 |
Denali Therapeutics | DNLI | Nov 22, 2024 | 24.69 | +1.94 |
Denison Mines | DNN | Nov 22, 2024 | 2.39 | +1.27 |
Dennys | DENN | Nov 22, 2024 | 6.25 | -2.19 |
DENTSPLY SIRONA | XRAY | Nov 22, 2024 | 18.77 | +0.70 |
Dermata Therapeutics | DRMA | Nov 22, 2024 | 1.14 | -1.12 |
Descartes Systems Group | DSGX | Nov 22, 2024 | 116.08 | +1.53 |
Design Therapeutics | DSGN | Nov 22, 2024 | 5.62 | +0.90 |
Designer Brands A | DBI | Nov 22, 2024 | 5.04 | +3.07 |
Desktop Metal A | DM | Nov 22, 2024 | 4.42 | +0.45 |
Despegar.com | DESP | Nov 22, 2024 | 18.75 | +1.41 |
Destiny Tech100 | DXYZ | Nov 22, 2024 | 41.97 | +6.31 |
Destra Multialternative Fund | DMA | Nov 22, 2024 | 8.91 | +1.71 |
Deswell Industries | DSWL | Nov 22, 2024 | 2.62 | +0.01 |
Deutsche Bank | DB | Nov 22, 2024 | 16.20 | -3.57 |
Dev Mkts Ex-US Alphadex First Trust | FDT | Nov 22, 2024 | 55.85 | -0.18 |
Dev Mkts Ex-US SC Alphadex First Trust | FDTS | Nov 22, 2024 | 41.07 | +0.81 |
Devon Energy | DVN | Nov 22, 2024 | 39.45 | +1.94 |
DevvStream | DEVS | Nov 22, 2024 | 0.55 | 0.00 |
DexCom | DXCM | Nov 22, 2024 | 72.83 | -2.19 |
DHI Group | DHX | Nov 22, 2024 | 1.73 | -1.14 |
DHT | DHT | Nov 22, 2024 | 10.23 | -1.35 |
Diageo ADR | DEO | Nov 22, 2024 | 120.09 | +1.69 |
DiaMedica Therapeutics | DMAC | Nov 22, 2024 | 4.70 | +12.44 |
Diamond Hill Investment Group A | DHIL | Nov 22, 2024 | 170.56 | +0.54 |
Diamondback Energy | FANG | Nov 22, 2024 | 185.29 | +1.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.